Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1Maike Janssen, Sascha Dietrich, Christian Rohde et al.|Blood|2022Cited by 100
LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastomaHamed Alborzinia, José Pedro Friedmann Angeli, Zhiyi Chen et al.|EMBO Molecular Medicine|2023Cited by 75